JULIA P GREGORY
CIK 1226675 · CEO · last filed 2026-05-15
JULIA P GREGORY is a CEO who has filed 28 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for NRIX, was dated May 15, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $471.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$471.7K
7
28
-$2.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NRIX | Director | 10,750 | $16.95 | $182.2K | $0 | 7 | 2026-05-15 |
| BHVN | Director | 25,665 | $11.28 | $289.5K | -$2.58M | 13 | 2025-05-07 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Director | — | — | — | $0 | 1 | 2022-10-03 |
| CONTRAFECT Corp (CFRX.W) Delisted | CEO | — | — | — | $0 | 1 | 2016-02-17 |
| CONTRAFECT Corp (CFRX.Z) Delisted | CEO | 50,283 | — | — | $54.3K | 3 | 2015-03-03 |
| LXRX | EVP and CFO | — | $1.92 | — | $0 | 1 | 2008-02-11 |
| LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | EVP, Corp Dev and CFO | — | — | — | $0 | 1 | 2007-02-15 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | NRIX | Grant (A) | — | $0 | EDGAR |
| 2025-09-17 | NRIX | Exer (M) | +10,750 | $20.0K | EDGAR |
| 2025-05-19 | NRIX | Grant (A) | — | $0 | EDGAR |
| 2025-05-07 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2024-05-20 | NRIX | Grant (A) | — | $0 | EDGAR |
| 2024-05-02 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2023-05-04 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2023-05-04 | NRIX | Grant (A) | — | $0 | EDGAR |
| 2022-10-26 | BHVN | Buy (P) | +9,523 | $100.0K | EDGAR |
| 2022-10-05 | — | Mixed | +16,142 | -$14 |